Papers/PMID:26770927
Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.
Clinical and molecular hepatology2015The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
α-tocopherol — no detected effect on fasting blood glucose
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×3“During the 6-month treatment period, vitamin E did not induce significant changes in body weight, fasting serum glucose or lipid levels compared to control (Table 2).”
Quoted verbatim from Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.. - Study
- cohort
- Duration
- 6 months
- Dose
- vitamin E (alpha-tocopherol), average 883 IU/day
- Population
- Propensity-score matched retrospective cohort of NAFLD patients with metabolic syndrome and elevated ALT; controls followed on lifestyle modification without vitamin E
Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.2015PMID:26770927Permalink